“Pharmacoeconomic Comparison of Ziprasidone With Other Atypical Oral Antipsychotic Agents in Schizophrenia”. 2011. Farmeconomia. Health Economics and Therapeutic Pathways 12 (1): 29-40. https://doi.org/10.7175/fe.v12i1.96.